Off-label uses of monoclonal antibodies for treatment of B-cell lymphoid or myeloid malignancies.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D054598:Blue Cross Blue Shield Insurance Plans; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D016393:Lymphoma, B-Cell / Q000628:therapy*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal